Sage Journals: Discover world-class research

Retricted access

Research article

First published 2021-3

Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri ® Observational Program (TOP)

Helmut Butzkueven, Maria Trojano, Ludwig Kappos [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2019

The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri ® PharmacoEconomics (TyPE) Study

B Polistena, F Spandonaro, R Capra [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Research article

First published 2018-6

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study

Ludwig Kappos, Helmut Butzkueven, Heinz Wiendl [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2012-6

Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped

Theo Rispens, Anke Vennegoor, Gert Jan Wolbink [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2023

IgM to phosphatidylcholine in multiple sclerosis patients: from the diagnosis to the treatment

Isabel Sánchez-Vera, Esther Escudero, Úrsula Muñoz [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Review article

First published 2010-10

PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis

Darren P. Baker, Robert Blake Pepinsky, Margot Brickelmaier [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2011-2

An approach to natalizumab hypersensitivity: a case series of induction of tolerance

Marie Camacho-Halili, Roxanne George, Malcolm Gottesman [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2015-2

Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective,controlled observational study

Neda Ebrahimi, Sandra Herbstritt, Ralph Gold [...]

Multiple Sclerosis Journal

Search results